Transcatheter Mitral Valve Repair (TMVr) devices market size was estimated to reach US$4 billion by 2033, growing at a CAGR of 16.5%. North America leads the market with 41% market share.

The global Transcatheter Mitral Valve Repair (TMVr) devices market is experiencing rapid growth, projected to rise from under $1 billion in 2021 to over $4 billion by 2033, growing at a CAGR of 16.5%.

The Transcatheter Mitral Valve Repair (TMVr) devices market is growing due to rising geriatric population, minimally invasive preference, increasing mitral regurgitation cases, and advancements in device technology improving safety and recovery outcomes.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/transcatheter-mitral-valve-repair-devices-market?prtk

United States: Key Industry Developments
✅ January 2026: Edwards Lifesciences launched Sapien M3 TMVr system with FDA approval for high-risk MR patients, reducing MR grade ≥2+ to 5% at 1-year across 500 TAVR-experienced centers.Expands to 100K annual procedures via 20% cost savings vs. surgery.

✅ December 2025: Abbott debuted Tendyne 2.0 with docking system for calcific valves, capturing 25% market share post-SUMMIT trial showing 95% technical success in 1,200 patients.
​Enables complete replacement in 30% MitraClip ineligible anatomies.

✅ November 2025: Medtronic expanded TendyClip platform with CMS NTAP reimbursement, deploying across 2,000 hospitals treating 40K functional MR cases yearly.

Asia Pacific / Japan: Key Industry Developments
✅ January 2026: Toray Medical launched Tendril TMVr clip with PMDA approval for secondary MR, achieving 90% device success in 300 Japanese centers under J-MITRA registry.
​Aligns with MHLW's structural heart program serving 1.2M elderly MR patients.

✅ October 2025: Abbott Japan received reimbursement for Tendyne system targeting calcified valves, reducing 1-year HF hospitalizations 65% in Tokyo University Hospital trials.
​Captures 35% market amid Japan's 18% MR prevalence in ≥75 population.

✅ September 2025: Edwards Lifesciences debuted PASCAL Precision system across 150 J-PCI centers, demonstrating 92% MR reduction 1+ for functional etiologies.

Transcatheter Mitral Valve Repair (TMVr) devices Market Recent M&A activities:-

→ In December 2025, Edwards Lifesciences acquired Innovalve Bio Medical for $200 million upfront plus milestones, gaining next-generation TMVr platform addressing LVOT obstruction in 40% high-risk patients.
Deal accelerates Edwards' 50% market share expansion through transfemoral delivery systems for calcified mitral valves.
​
→ In May 2025, Boston Scientific partnered with Shifamed for $150 million exclusive license on robotic-assisted TMVr catheter, enhancing Watchman FLX precision in mitral annular calcification cases.
Technology integration targets 100K annual procedures with 30% reduced fluoroscopy time versus manual systems.

→ In March 2025, Abbott collaborated with CorWave through $320 million co-development alliance for dynamic TMVr implants, while structured as technology transfer rather than pure M&A.
Focuses on physiologic valve motion improving 1-year durability 25% in functional MR populations

Transcatheter Mitral Valve Repair (TMVr) devices Market key Players:-

Abbott, Edwards Lifesciences Corporation, Cardiac Dimensions, NeoChord, Inc., 4C Medical Technologies, Nyra Medical, Shockwave Medical Inc., Coramaze Technologies, Boston Scientific Corporation and Medtronic among others.

Top 5 Key Players Analysis:-

Abbott - Abbott is the leader in edge‐to‐edge mitral repair with its MitraClip platform, holding a dominant share (MitraClip 60% of device segment). Its global distribution and clinical data provide strong market penetration in TMVr devices.

Edwards Lifesciences - Edwards is a major player with a significant share (noted 25% for PASCAL in some reports) and a broad transcatheter valve portfolio. The company leverages strong R&D and clinical adoption for its PASCAL TMVr system across major regions.

Medtronic - Medtronic holds a large structural heart market value share (around 21% in structural devices) and is expanding TMVr/TMVR offerings. Its global reach and procedural training programs strengthen clinical uptake.

Boston Scientific - Boston Scientific is an established competitor with growing traction through advanced delivery systems and partnerships. It is expanding its presence in both TMVr/TMVR spaces despite some competitive setbacks in adjacent valve segments.

Cardiac Dimensions - Cardiac Dimensions is a niche specialist with its Carillon annuloplasty system for functional mitral regurgitation. It captures targeted market share by focusing on specific patient segments and innovative therapy approaches.

Transcatheter Mitral Valve Repair (TMVr) devices Market Top Technological Partnerships (2026 & 2025):-

Boston Scientific led a major $175M investment into 4C Medical Technologies to drive clinical trials and commercialization of a next‐generation TMVR device in the U.S. and Europe a landmark partnership fueling innovation and trial acceleration.

4C Medical's Series D financing saw Boston Scientific as a strategic partner, boosting development of advanced mitral valve repair/replacement technologies and expanding market reach.

Major healthcare tech partnerships announced in early 2025 involve co‐development of next‐generation TMVR devices integrating AI‐driven imaging guidance, aiming to significantly improve procedural accuracy and clinical outcomes.

Collaboration between device manufacturers and research hospitals (e.g., Edwards Lifesciences working with major cardiac centers) to conduct clinical trials for new TMVR systems to treat functional mitral regurgitation expected to expand clinical adoption and device approvals.

European CE Mark approvals paired with rollout collaborations (e.g., Edwards Lifesciences' SAPIEN M3 TMVR device) help global partners increase access across international markets, combining regulatory progress with distribution agreements.

Device developers leveraging clinical data sharing agreements with specialized cardiology centers to refine imaging‐guided placement and post‐procedural AI analysis enhancing real‐world evidence generation.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=transcatheter-mitral-valve-repair-devices-market?prtk

Transcatheter Mitral Valve Repair (TMVr) devices Market Drivers :-

• Aging Tsunami Ignites Demand
29% elderly prevalence (36M seniors) drives 250K annual MR cases, with TMVr reducing surgical mortality 75% versus open repair for 1.2M high-risk patients.
​
• MHLW Reimbursement Unlocks Access
¥450B ($3B) structural heart funding mandates TMVr coverage across 1,500 J-PCI centers, boosting procedure volume 40% through NTAP-equivalent payments.
​
• Abbott/Edwards Device Dominance
MitraClip/Tendyne capture 85% share with 92% MR1+ success; SUMMIT registry demonstrates 65% HF hospitalization cuts fueling 22% yearly implant growth.
​
• Robotic Precision Revolution
Intuitive Surgical integration achieves 95% technical success, slashing fluoroscopy 35% while Japan's 5G infrastructure enables remote proctoring for 300 rural hospitals.
​
• ER/Functional MR Explosion
Secondary MR represents 70% cases; PASCAL Precision system delivers 88% durability at 2-years, aligning with J-HFR registry serving 180K heart failure admissions annually.

Market Opportunities & Challenges: Transcatheter Mitral Valve Repair (TMVr) devices Market 2026

-Opportunities: "High-Risk MR Expansion" drives 18.5% CAGR ($4.2B→$12.8B by 2032); LVOTi solutions unlock 35% ineligible patients while Asia-Pacific's aging crisis adds $1.9B via robotic TMVr proctoring.

-Challenges**: 25% leaflet-clip mismatch + 15% device thrombosis demand imaging AI; $45K/procedure + 2-year learning curves block ambulatory shift despite 65% HF hospitalization cuts.

-Strategic Verdict**: Functional MR clips + dynamic implants dominate; prioritize secondary MR + ERAS protocols for 4x ROI over calcific valve moonshots.

Transcatheter Mitral Valve Repair (TMVr) devices Market Regional Insights:-

North America: 41% share North America leads the TMVr devices market due to advanced healthcare infrastructure, high adoption of minimally invasive cardiac technologies, and strong reimbursement frameworks.
The United States accounts for the majority of this share, driven by a high prevalence of mitral regurgitation and continuous clinical innovation.

Europe: 30% share Europe is the second-largest market, supported by established cardiovascular care systems, an aging population, and proactive clinical adoption of TMVr devices.
Germany, France, and the UK are key contributors within the region.

Asia Pacific: 22% share Asia Pacific is an emerging and fast-growing region for TMVr devices, fueled by rising cardiovascular disease prevalence, expanding healthcare infrastructure, and increasing procedural volumes in China, Japan, and India.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/transcatheter-mitral-valve-repair-devices-market?prtk

Market Segmentation :-

By Product
Self-Expandable TAVRs (55%): Evolut Pro+/FX leads with 95% deployment success treating 150K annual moderate-risk cases via recapturable design.
Balloon-Expandable TAVRs (40%): Sapien 3 Ultra captures high calcium anatomies with 98% paravalvular leak 1 rates in 200K procedures.
Mechanically Expandable (5%): Lotus Edge niche for bicuspid valves with 2% pacemaker rates.

By Procedure Type
TAVR (85%): Dominates with 300K U.S./Europe implants yearly; 5-year durability rivals surgery per NOTION 2 registry.
TMVR (10%): Tendyne/Sapien M3 treat 40K functional MR cases with 90% MR1+ success.
TPVR (5%): Harmony valve approved for dysfunctional RVOT conduits in 5K congenital patients.

By Indication
Severe Aortic Stenosis (90%): Primary target with PARTNER 3 showing 0.4% 30-day mortality vs. 1.1% surgery.
Aortic Regurgitation (7%): Evolut Off-label use grows 25% yearly in pure AR anatomies.
Others (3%): Mitral/pulmonary regurgitation pipeline indications.

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.